Patent details

EP1309557 Title: AMLODIPINE HEMIMALEATE

Basic Information

Publication number:
EP1309557
PCT Application Number:
PCT/NL/2001/000602
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP019749845
PCT Publication Number:
WO/2002/053539
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
AMLODIPINE HEMIMALEATE
French Title of Invention:
AMLODIPINE HEMIMALEATE
German Title of Invention:
AMLODIPIN-HEMIMALEAT
SPC Number:

Dates

Filing date:
15/08/2001
Grant date:
04/01/2006
EP Publication Date:
04/01/2006
PCT Publication Date:
11/07/2002
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
14/05/2003
EP B1 Publication Date:
04/01/2006
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
15/08/2006
Expiration date:
15/08/2021
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
15/08/2001
 
 

Name:
Pfizer Limited
Address:
261 Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom (GB)

Inventor

Name:
ETTEMA Gerrit, Jan, Bouke
Address:
Netherlands (NL)

Priority

1

Priority Number:
258603 P
Priority Date:
29/12/2000
Priority Country:
United States (US)

2

Priority Number:
809356
Priority Date:
16/03/2001
Priority Country:
United States (US)

Classification

Main IPC Class:
C07D 211/90;
Filing date Document type Number of pages